LS-1727
Experimental drug
LS-1727 is an experimental pharmaceutical drug that has been studied for its potential effects on the central nervous system. It is classified as a urea derivative and has been primarily investigated for its anxiolytic and antidepressant properties.
Chemical Structure and Properties
LS-1727 is a chemical compound with the IUPAC name 1-(4-chlorophenyl)-3-(2,6-dimethylphenyl)urea. The compound consists of a urea moiety linked to a 4-chlorophenyl group and a 2,6-dimethylphenyl group. The presence of the chlorine atom and the methyl groups contribute to its unique pharmacological profile.
Pharmacology
LS-1727 has been shown to interact with various neurotransmitter systems in the brain. It is believed to modulate the activity of gamma-aminobutyric acid (GABA) receptors, which are involved in the regulation of anxiety and mood. The compound may enhance the inhibitory effects of GABA, leading to its potential anxiolytic and antidepressant effects.
Mechanism of Action
The exact mechanism of action of LS-1727 is not fully understood. However, it is hypothesized that the compound acts as a positive allosteric modulator of GABAA receptors. This modulation increases the inhibitory neurotransmission in the brain, which can result in reduced anxiety and improved mood.
Potential Therapeutic Uses
LS-1727 is being researched for its potential use in treating anxiety disorders and depression. Its ability to modulate GABAergic activity makes it a candidate for conditions where these neurotransmitter systems are dysregulated.
Research and Development
As of the latest updates, LS-1727 is still in the preclinical stages of development. Studies are ongoing to determine its safety, efficacy, and pharmacokinetics. Further research is needed to fully understand its therapeutic potential and to evaluate its effects in clinical trials.
Related pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD